On Tuesday, 20 May 2025, Regeneron Pharmaceuticals (NASDAQ:REGN) presented at the RBC Capital Markets Global Healthcare Conference ... Factor XI Program: This initiative aims to develop a safer ...

RethinkFirst, a leading global health technology company and solutions provider in behavioral health and neurodiversity, today announced four new additions to its leadership team who will be at the ...

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...

AI's impact in healthcare includes improved diagnostics, early disease detection, and enhanced drug discovery. Companies like IBM and Google's DeepMind apply AI in precision medicine and medical ...

While processing this data individually can deliver important insights, combining them can create a clearer, more complete picture of a patient’s health. This is called multimodal AI.

Regeneron and GlaxoSmithKline have joined forces to generate genetic sequence data from the 500,000 volunteers in the UK’s Biobank database. The companies hope the initiative will give insights ...

Radicle Science, a health tech company bringing trusted clinical evidence to everyday wellness and natural products, welcomes Liya Sharif Lancia as its chief marketing officer. This latest addition to ...

Microsoft on Tuesday afternoon announced the 20 Washington state organizations and initiatives ... health, and education and the public good, and were selected through the AI for Good Open Call ...